Depei Wu
The First Affiliated Hospital of Soochow University · Study Principal Investigator · First Affiliated Hospital of Soochow University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Depei Wu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:54 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07500753 · A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly PatientsThe First Affiliated Hospital of Soochow University · recruiting · Relapsed or Refractory Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome) · study chair
- N/ANCT07499284 · A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic AnemiaThe First Affiliated Hospital of Soochow University · recruiting · Aplastic Anaemia · study chair
- Ph3NCT07486479 · Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AMLThe First Affiliated Hospital of Soochow University · not yet recruiting · Acute Myeloid Leukemia (AML) · principal investigator
- N/ANCT06879847 · A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AMLThe First Affiliated Hospital of Soochow University · recruiting · Relapsed or Refractory Acute Myeloid Leukemia · study chair
- N/ANCT06548958 · A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic DiseasesThe First Affiliated Hospital of Soochow University · recruiting · Malignant Hematological Diseases · principal investigator
- Ph1NCT06234904 · Study of IBR733 Cell Injection in Acute Myeloid LeukemiaImbioray (Hangzhou) Biomedicine Co., Ltd. · recruiting · Acute Myeloid Leukemia · principal investigator
- N/ANCT06142175 · Relmacabtagene Autoleucel in Patients With LBCLShanghai Ming Ju Biotechnology Co., Ltd. · unknown · Large B-cell Lymphoma · principal investigator
- Ph2NCT06093841 · Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHLShanghai Ming Ju Biotechnology Co., Ltd. · active not recruiting · Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma · principal investigator
- Ph1/Ph2NCT06052813 · A Study of BN104 in the Treatment of Acute LeukemiaInstitut de Recherches Internationales Servier (I.R.I.S.) · active not recruiting · ALL, Adult, AML, Adult, Acute Leukaemia · principal investigator
- Ph2NCT05823714 · Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCTThe First Affiliated Hospital of Soochow University · unknown · Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome · study chair
- Ph2NCT05809167 · Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCTThe First Affiliated Hospital of Soochow University · unknown · Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia · study chair
- Ph1/Ph2NCT05647512 · Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell DiseasesLaNova Medicines Limited · withdrawn · Relapsed or Refractory Multiple Myeloma, Other Plasma Cell Diseases · principal investigator
- Ph1NCT05641259 · A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMMLGuangzhou Lupeng Pharmaceutical Company LTD. · recruiting · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia · study chair
- N/ANCT05587881 · Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell TransplantationThe First Affiliated Hospital of Soochow University · withdrawn · Hematologic Diseases · study chair
- Ph2NCT05510505 · GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCTThe First Affiliated Hospital of Soochow University · unknown · Aplastic Anemia · principal investigator
- Ph2/Ph3NCT05466201 · The Use of Eltrombopag Post HSCT in BMFDThe First Affiliated Hospital of Soochow University · completed · Stem Cell Transplant Complications · study chair
- Ph1/Ph2NCT05381662 · CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation TreatmentShanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd · unknown · Acute Lymphoblastic Leukemia in Remission · study chair
- Ph2NCT05322330 · Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's LymphomaThe First Affiliated Hospital of Soochow University · completed · Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma · study chair
- Ph2NCT05312476 · Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's LymphomaThe First Affiliated Hospital of Soochow University · withdrawn · Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma · study chair
- Ph2NCT05241106 · A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)Tarapeutics Science Inc. · unknown · Relapsed or Refractory Acute Myeloid Leukemia (AML) · principal investigator
- Ph2NCT05241093 · A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)Tarapeutics Science Inc. · unknown · Relapsed or Refractory Acute Myeloid Leukemia (AML) · principal investigator
- Ph2NCT05182957 · Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell LymphomaThe First Affiliated Hospital of Soochow University · recruiting · Relapsed/Refractory Peripheral T-cell Lymphoma · study chair
- Ph1/Ph2NCT05140616 · Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHDThe First Affiliated Hospital of Soochow University · unknown · Safety and Efficacy · study chair
- Ph2NCT05059912 · CD7 CAR T-cell for R/R CD7+ T Cell LymphomaThe First Affiliated Hospital of Soochow University · unknown · Refractory and Relapsed T Cell Lymphoma · study chair
- Ph2NCT04930562 · Efficacy and Safety of BN101 in Subjects With Chronic Graft Versus Host Disease (cGVHD)BioNova Pharmaceuticals (Shanghai) LTD. · completed · GVHD, Chronic · principal investigator
- N/ANCT04923789 · A Study of ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell LymphomaThe First Affiliated Hospital of Soochow University · completed · Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma · study chair
- Ph1/Ph2NCT04900350 · A Trial of AK117 (Anti-CD47) in Patients With Myelodysplastic SyndromeAkeso · active not recruiting · Myelodysplastic Syndrome · principal investigator
- Ph2NCT04835870 · Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCLThe First Affiliated Hospital of Soochow University · unknown · Non-GCB/ABC Diffuse Large B-Cell Lymphoma · study chair
- N/ANCT04660487 · Relationship Between "FODMAPs" and "GVHD"The First Affiliated Hospital of Soochow University · recruiting · Graft Versus Host Disease · study chair
- Ph2NCT04539444 · A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell LymphomaThe First Affiliated Hospital of Soochow University · completed · Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma · study chair
- Ph1/Ph2NCT03919240 · CAR-T Cell Therapy Targeting to CD19 for R/R ALLThe First Affiliated Hospital of Soochow University · active not recruiting · Acute Lymphoblastic Leukemia With Failed Remission · principal investigator
- Ph3NCT03719534 · Haplo HCT vs Haplo-cord HCT for Patients With AMLThe First Affiliated Hospital of Soochow University · completed · Hematopoietic Stem Cell Transplantation, Haplo-identical Donor, Cord Blood Unit · principal investigator
- N/ANCT03715621 · Prognostic Values of Next Generation Sequencing (NGS) in Acute Myeloid Leukemia Patients With Allo-HSCTThe First Affiliated Hospital of Soochow University · unknown · Acute Myeloid Leukemia · principal investigator
- Ph1/Ph2NCT03455972 · Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCTThe First Affiliated Hospital of Soochow University · active not recruiting · Safety and Efficacy · study chair
- Ph2/Ph3NCT03256071 · Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCTThe First Affiliated Hospital of Soochow University · unknown · Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning · principal investigator
- Ph3NCT03252925 · A Safety and Efficacy Study of NAC in Patients With TA-TMAThe First Affiliated Hospital of Soochow University · completed · Thrombotic Microangiopathies, Hematologic Diseases · study chair
- N/ANCT03148743 · FMT in Gut aGVHD TreatedThe First Affiliated Hospital of Soochow University · recruiting · Acute-graft-versus-host Disease · study chair
- Ph3NCT02487563 · Prospective Study of Patients With Thrombocytopenia Following HSCTThe First Affiliated Hospital of Soochow University · completed · Thrombocytopenia, Hematologic Diseases · study chair
- Ph3NCT02323022 · Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML)The First Affiliated Hospital of Soochow University · completed · Acute Myeloid Leukemia · principal investigator
- Ph3NCT02059720 · Haplo-SCT vs ASCT With or Without Decitabine in AML CR1The First Affiliated Hospital of Soochow University · unknown · Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:54 UTC. The ranking covers the 200 most relevant of 701 PubMed records, and a shared surname and initials can bring in a namesake. All 701 on PubMed
- 470 citationsRCR 33.7
- 384 citationsRCR 22.8
- Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.J Clin Oncol · 2023321 citationsRCR 26.4
- 208 citationsRCR 20.3
- 193 citationsRCR 16.8
- 187 citationsRCR 14.2
- Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.J Clin Invest · 2014185 citationsRCR 5.4
- Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients.Am J Transplant · 2011165 citationsRCR 5.0
- Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.Signal Transduct Target Ther · 2023156 citationsRCR 12.7
- Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nat Med · 2024145 citationsRCR 14.6